Adrenoleukodystrophy: A Clinical, Pathological and Biochemical Study
- 60 Downloads
The association of diffuse cerebral demyelination and adrenal disease was first adequately described by Siemerling and Creutzfeldt in 1923 (13). The report of Siemerling and Creutzfeldt was followed by similar isolated case studies. Despite the startling nature of these reports, the association of adrenal atrophy and cerebral demyelination was considered coincidental, and these cases were usually described as melanodermic leukodystrophy or brown Schilder’s disease. The studies of Gagnon and Leblanc in 1959 (4), Hoefnagel et al. in 1962 (5) and especially Fanconi et al. in 1963 (3) established this combination of neurologic and endocrine abnormalities as a hereditary disease, probably with a sex-linked recessive transmission. Since that time there have been at least 40 well-documented cases. Blaw, in 1971, introduced the term adrenoleukodystrophy (ALD) to describe this condition (1). Our identification, in 1972 of specific light microscopic cytoplasmic changes in the adrenal cortical cells of nine males diagnosed as having Schilder’s disease (10), and the subsequent ultrastructural characterization of the inclusions (7), led to the recognition of similar abnormal inclusions in Schwann cells, testis, and brain (8, 11, 12).
KeywordsSchwann Cell Cholesterol Ester Adrenal Cortical Cell Lipid Storage Disease Fatty Acid Abnormality
Unable to display preview. Download preview PDF.
- 1.Blaw, M.E.: Melanodermie type leukodystrophy (adreno-leukodystrophy) in Vinken, P.G., Bruyn, G.W. Handbook of Clinical Neurology, New York, American Elsevier, 1970, Vol. 10, pp 128–133.Google Scholar
- 3.Fanconi, V.A., Prader, A., Iser, W., Luthy, F. and Siebenmann, R.: Morbus Addison mit Hirnsklevose in Kindesalter Ein heritares Syndrom mit x-chronosomaler Verebung? Helv. Pediatr. Acta 13: 480, 1963.Google Scholar
- 4.Gagnon, J. and Leblanc, R.: Sclerose cerebrale diffuse avec melanodermie et atrophy surrenale. Un Med. Can. 88: 391, 1959.Google Scholar
- 6.Igarashi, M., Schaumburg, H.H., Powers, J.M., Kishimoto, Y., Kolodny, E.H. and Suzuki, K.: Fatty acid abnormality in adrenoleukodystrophy. J. Neurochem., in press.Google Scholar
- 9.Richardson, E.P.: Schilder’s disease: What is it? J. Neuropath. Exp. Neurol., in press.Google Scholar